The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The mechanisms leading to degeneration of dopaminergic neurons (DNs) in the substantia nigra of patients with Parkinson's disease (PD) are not completely understood. Here, we show, in the postmortem human tissue, that these neurons aberrantly express mitosis-associated proteins, including the E2F-1 transcription factor, and appear to duplicate their nuclear DNA. We further demonstrate that the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injected into mice and application of its active metabolite 1-methyl-4-phenylpyridinium to mesencephalic cultures activate the retinoblastoma–E2F pathway in postmitotic DNs. We also find that cell death rather than mitotic division followed the toxin-induced replication of DNA, as determined by BrdU incorporation in DNs. In addition, blocking E2F-1 transcription protected cultured DNs against 1-methyl-4-phenylpyridinium toxicity. Finally, E2F-1-deficient mice were significantly more resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic cell death than their wild-type littermates. Altogether, BrdU incorporation in mature neurons and lack of evidence for newborn neurons argue against neuronal turnover in normal conditions or during pathological states in the substantia nigra. Instead, our results demonstrate that mitosis-like signals are activated in mature DNs in patients with PD and mediate neuronal death in experimental models of the disease. Inhibition of mitosis-like signals may therefore provide strategies for neuroprotection in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study reported increased levels of the E2F-1 transcription factor in dopaminergic neurons in the substantia nigra of PD patients and suggested that the pRb/E2F-1 pathway is activated in these neurons which can lead to apoptosis [251].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [251]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., & Greenberg, M. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81255-6 · Cited by 754
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D. S., & Herrup, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 616
The harlequin mouse mutation downregulates apoptosis-inducing factor
Klein, J. A., Longo-Guess, C. M., Rossmann, M. P., Seburn, K. L., Hurd, R. E., Frankel, W. N., Bronson, R. T., & Ackerman, S. L. (2002) · Nature · doi:10.1038/nature01034 · Cited by 605
Evidence for neurogenesis in the adult mammalian substantia nigra
Zhao, M., Momma, S., Delfani, K., Carlén, M., Cassidy, R. M., Johansson, C. B., Brismar, H., Shupliakov, O., Frisén, J., & Janson, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131955100 · Cited by 590
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483
The Adult Substantia Nigra Contains Progenitor Cells with Neurogenic Potential
Lie, D. C., Dziewczapolski, G., Willhoite, A. R., Kaspar, B. K., Shults, C. W., & Gage, F. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06639.2002 · Cited by 449
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 319
The genetics of the E2F family of transcription factors: shared functions and unique roles
DeGregori, J. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00051-3 · Cited by 295
Self-citation
Cited by
Items 101–200 of 277
Lopes, J. P., Blurton-Jones, M., Yamasaki, T. R., Agostinho, P., & LaFerla, F. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0993 · Cited by 32
“5b, B). els of PCNA [16,18,27].”
A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis
Norsworthy, P. J., Thompson, A. G. B., Mok, T. H., Guntoro, F., Dabin, L. C., Nihat, A., Paterson, R. W., Schott, J. M., Collinge, J., Mead, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17655-x · Cited by 39
Activation of ataxia telangiectasia muted under experimental models and human Parkinson’s disease
Camins, A., Pizarro, J. G., Alvira, D., Cuesta, J., de la Torre, A. V., Folch, J., Sureda, F. X., Verdaguer, E., Junyent, F., Jordán, J., et al. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0408-5 · Cited by 32
“Our hypothesis was based on the evidence that pharmacological CDK inhibitors such as flavopiridol showed neuroprotective and antiapoptotic effects against MPP ? in vitro and also in vivo [ 16 , 19].”
BackgroundYeste‐Velasco, M., Folch, J., Trullás, R., Abad, M. A., Enguita, M., Pallàs, M., & Camins, A. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.012 · Cited by 36
Simpson, M. T., Venkatesh, I., Callif, B. L., Thiel, L. K., Coley, D. M., Winsor, K. N., Wang, Z., Kramer, A. A., Lerch, J. K., & Blackmore, M. G. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.08.008 · Cited by 37
“…is particularly important given the involvement of HHEX in cell proliferation in non-neuronal cells, and findings that modulation of cell cycle regulators can induce apoptosis in post-mitotic neurons (Kranenburg et al., 1996 and Nguyen et al., 2002; Greene et al., 2004 and Hoglinger et al., 2007).”
Hamdane, M., & Buée, L. (2007) · Biotechnology Journal · doi:10.1002/biot.200700059 · Cited by 38
“The same study demonstrated that activation of the RbE2F pathway was also found in DNs of a Parkinson’s mice model, and inhibition of this pathway provides a protective effect against neuronal cell death [108].”
BackgroundSurvivin Mutant Protects Differentiated Dopaminergic SK-N-SH Cells Against Oxidative Stress
Baratchi, S., Kanwar, R. K., & Kanwar, J. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015865 · Cited by 32
“For example, cyclin D1 expression has been observed in DArgic neurons in the postmortem substantia nigra pars compacta (SNc) of PD patients [22,23,24,25,26].”
BackgroundSorhun, D. T., Abdik, H., Sahin, F., & Abdik, E. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173342 · Cited by 37
Neurogenesis in Substantia Nigra of Parkinsonian Brains?
Arias-Carrión, Ó., Yamada, E. S., Freundlieb, N., Djufri, M., Maurer, L., Hermanns, G., Ipach, B., Chiu, W., Steiner, C., Oertel, W. H., et al. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_23 · Cited by 32
Self-citationWei, M., Liu, Y., Pi, Z., Li, S., Hu, M., He, Y., Yue, K., Liu, T., Liu, Z., Song, F., et al. (2019) · Molecules · doi:10.3390/molecules24071203 · Cited by 31
“neuronal cell cycle plays an important role in several central nervous system diseases [39,40], and is also a significant contributor to regionally specific neuronal death in AD [41].”
BackgroundAging and Alzheimer’s disease connection: Nuclear Tau and lamin A
Gil, L., Niño, S. A., Capdeville, G., & Jiménez-Capdeville, M. E. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135741 · Cited by 31
Bedford, L., Hay, D., Paine, S., Rezvani, N., Mee, M., Lowe, J. S., & Mayer, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.009 · Cited by 36
Merlo, S., Basile, L., Giuffrida, M. L., Sortino, M. A., Guccione, S., & Copani, A. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00621 · Cited by 28
Sampaio‐Marques, B., Guedes, A., Vasilevskiy, I., Gonçalves, S., Outeiro, T. F., Winderickx, J., Burhans, W. C., & Ludovico, P. (2019) · Aging Cell · doi:10.1111/acel.12922 · Cited by 27
“For example, elevated levels of proteins involved in cell cycle re‐entry and DNA synthesis in dopaminergic neurons are observed in the brain of PD patients (Hoglinger et al., 2007).”
BackgroundDiao, H., Li, X., Hu, S. C., & Liu, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052319 · Cited by 30
“E2F1 immunoreactivity and/or protein levels were reported to increase in neurons of patients with PD [38].”
BackgroundKubis-Kubiak, A., & Piwowar, A. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.008 · Cited by 31
Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity
Suzuki, E., Zhao, Y., Ito, S., Sawatsubashi, S., Murata, T., Furutani, T., Shirode, Y., Yamagata, K., Tanabe, M., Kimura, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809819106 · Cited by 28
Linking Cell Cycle Reentry and DNA Damage in Neurodegeneration
Kim, D., & Tsai, L. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04105.x · Cited by 28
Alquézar, C., Esteras, N., de la Encarnación, A., Alzualde, A., Moreno, F., de Munaín, A. L., & Martín‐Requero, Á. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.021 · Cited by 30
Disrupted myelination network in the cingulate cortex of Parkinson's disease
Xie, S., Yang, J., Huang, S., Fan, Y., Xu, T., He, J., Guo, J., Ji, X., Wang, Z., Li, P., et al. (2022) · IET Systems Biology · doi:10.1049/syb2.12043 · Cited by 27
Alquézar, C., Esteras, N., Bartolomé, F. B., Merino, J. J., Alzualde, A., de Munaín, A. L., & Martín‐Requero, Á. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.020 · Cited by 31
“These include Alzheimer’s disease (AD), Parkinson’s disease (PD), ALS and others (Appert-Collin et al., 2006; Hoglinger et al., 2007).”
RNA metabolism in the pathogenesis of Parkinson׳s disease
Lu, B., Gehrke, S., & Wu, Z. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.003 · Cited by 28
“Interestingly, upregulation of E2F has been suggested to mediate cell death of dopaminergic neurons in patients with Parkinson's disease and in vertebrate models of the disease (Hoglinger et al., 2007).”
Cell Cycle Proteins as Key Regulators of Postmitotic Cell Death.
Xia, P., Liu, Y., Chen, J., & Cheng, Z. (2019) · PubMed Central · Cited by 32
Endogenous Regeneration in Parkinson's Disease: Do We Need Orthotopic Dopaminergic Neurogenesis?
Hermann, A., & Storch, A. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0567 · Cited by 25
Ye, J., Sun, X., Jiang, Q., Gui, J., Feng, S., Qin, B., Xie, L., Guo, A. W., Dong, J., & Sang, M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02773-1 · Cited by 33
“G2/M cell cycle arrest before cell death has been confirmed in dopaminergic neurons of PD patients [42, 43].”
BackgroundWorlitzer, M. M. A., Viel, T., Jacobs, A. H., & Schwamborn, J. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12269 · Cited by 27
“these two cells probably were mature neurons undergoing cell-cycle re-entry (Bauer & Patterson, 2005; Hoglinger et al., 2007).”
BackgroundG1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson’s Disease Patients
Esteras, N., Alquézar, C., Bartolomé, F. B., de la Encarnación, A., Bermejo‐Pareja, F., Molina, J. A., & Martín‐Requero, Á. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8870-y · Cited by 26
“Activation of the pRb pathway has been reported in PD brain and in mouse models of PD [7],”
Targeted gene mutation of E2F1 evokes age‐dependent synaptic disruption and behavioral deficits
Ting, J. H., Marks, D. R., Schleidt, S. S., Wu, J. N., Zyskind, J. W., Lindl, K. A., Blendy, J. A., Pierce, R. C., & Jordan‐Sciutto, K. L. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12655 · Cited by 33
Choi, B., D’Onofrio, P. M., Shabanzadeh, A. P., & Koeberle, P. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220056 · Cited by 24
Retinal Progenitor Cells, Differentiation, and Barriers to Cell Cycle Reentry
Davis, D. M., & Dyer, M. A. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-385044-7.00006-0 · Cited by 27
Insights into the regulation of neuronal viability by nucleophosmin/B23
Pfister, J. A., & D’Mello, S. R. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215579168 · Cited by 28
“Furthermore, in vivo knockout of E2F1 is protective against MPTP toxicity in mice, a compound known to induce PD-related symptoms.(97) In line with this is the finding that in the substantia nigra, midfrontal cortex and hippocampus of patients with PD, pRb phosphorylation is increased and is associated with Lewy Bodie…”
Aneuploidy in Lewy body diseases
Yang, Y., Shepherd, C. E., & Halliday, G. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.016 · Cited by 24
“These data expand previous evidence of hyperploidy in a small proportion of SN neurons in LBD using other methods (Hoglinger et al., 2007).”
InfluentialDNA polymerase-β is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons
Zhang, Z., Cao, X., Xiong, N., Wang, H., Huang, J., Sun, S., Liang, Z., & Wang, T. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0425-8 · Cited by 24
“In an MPTP-induced mouse model of PD, dopaminergic neurons were shown to undergo re-entry into the cell cycle and DNA replication [10].”
BackgroundInfluentialJeon, S. G., Kim, K. A., Chung, H., Choi, J., Song, E. J., Han, S. Y., Oh, M. S., Park, J. H., Kim, J.-I., & Moon, M. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0072 · Cited by 25
“It is well known that PCNA is not found in normal neurons but is found in NSCs (Hoglinger et al., 2007; Sierra et al., 2011).”
BackgroundA rare sequence variant in intron 1 of THAP 1 is associated with primary dystonia
Vemula, S. R., Xiao, J., Zhao, Y., Bastian, R. W., Perlmutter, J. S., Racette, B. A., Paniello, R. C., Wszołek, Z. K., Uitti, R. J., van Gerpen, J. A., et al. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.67 · Cited by 23
“2013), and contributes to the apoptotic dopaminergic cell death associated with Parkinson’s disease (Hoglinger et al. 2007).”
BackgroundRuggiero, R. P., Kale, A., Thomas, B. J., & Baker, N. E. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003049 · Cited by 22
Alquézar, C., Esteras, N., de la Encarnación, A., Moreno, F., de Munaín, A. L., & Martín‐Requero, Á. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.12.007 · Cited by 26
“…for PGRN-deficient FTLD. Cell cycle-related events are now considered as an important pathogenic mechanism for neurodegenerative disorders including Alzheimer disease (AD) (Mosch et al., 2007; Yang et al., 2001), Parkinson disease (PD) (Hoglinger et al., 2007), ALS and FTLD (Husseman et al., 2000).”
Serine-arginine protein kinases: new players in neurodegenerative diseases?
Chan, C. B., & Ye, K. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0014 · Cited by 23
“Moreover, increased DNA synthesis has been demonstrated in the neurons of AD and PD patients (Hoglinger et al., 2007; Mosch et al., 2007).”
BackgroundTargeting cyclin D3/ CDK 6 activity for treatment of Parkinson's disease
Alquézar, C., Barrio-Alonso, E., Esteras, N., de la Encarnación, A., Bartolomé, F. B., Molina, J. A., & Martín‐Requero, Á. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13070 · Cited by 25
“Activation of the pRb pathway has been reported in PD brain and in mouse models of PD (Hoglinger et al. 2007) although in neurons this leads to cell death rather than to cell division.”
BackgroundPotential Use of Flavopiridol in Treatment of Chronic Diseases
Srikumar, T., & Padmanabhan, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41342-6_9 · Cited by 21
Core cell cycle machinery is crucially involved in both life and death of post-mitotic neurons
Marlier, Q., D’aes, T., Verteneuil, S., Vandenbosch, R., & Malgrange, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03548-1 · Cited by 24
“Consistent with the central role of CDK5 in PD, truncated peptides of p35 (CDK5R1) that specifically inhibit the CDK5/ p25 complex rescue dopaminergic neurons and alleviate PD symptoms following MPTP treatment in mice [188–190].”
BackgroundInfluentialChen, Y. S., Chen, C., Song, D., Liu, T., & Cheng, O. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15252 · Cited by 23
“This is consistent with previous results on the midbrain neurons of embryonic rats exposed to MPP +(Höglinger et al., 2007) and mice exposed to MPTP(Smith et al., 2003).”
ResultAberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis
Kwon, B., Kumar, P., Lee, H., Zeng, L., Walsh, K. X., Fu, Q., Barakat, A., & Querfurth, H. W. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu077 · Cited by 21
DNA damage response and neuroprotection
Kruman, I. I. (2007) · Frontiers in bioscience · doi:10.2741/2862 · Cited by 24
Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division
Gupta, R. V., Jha, A., Ambasta, R. K., & Kumar, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120006 · Cited by 21
Association between PARK16 and Parkinson's disease in the Han Chinese population: a meta-analysis
Chang, K., Chen, C., Chen, Y.-C., Lyu, R.-K., Chang, H.-S., Ro, L., Lee‐Chen, G., & Wu, Y. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.028 · Cited by 20
“Given that cell-cycle proteins are integrally involved in the cell death of dopaminergic neurons (Hoglinger et al., 2007), the misregulation of NUCKS1 may contribute to the pathogenesis of PD.”
BackgroundMa, Q., Hu, Q., Xu, R., Zhen, X.-C., & Wang, G. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.48 · Cited by 20
Literature-Related Discovery (LRD)
Kostoff, R. N., Block, J. A., Solka, J. L., Briggs, M. B., Rushenberg, R. L., Stump, J. A., Johnson, D., Lyons, T. J., & Wyatt, J. R. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada473438 · Cited by 19
Khandia, R., Pandey, M. K., Zaki, M. E. A., Al‐Hussain, S. A., Baklanov, I. S., & Gurjar, P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1200523 · Cited by 18
“Increased Cyclin D and E levels are evident in degenerating neurons exposed to the neurotoxin 1-methyl-4phenylpyridinium (Höglinger et al., 2007).”
BackgroundIdentification of a novel functional deletion variant in the 5'-UTR of the DJ-1 gene
Keyser, R. J., van der Merwe, L., Venter, M., Kinnear, C. J., Warnich, L., Carr, J. A., & Bardien, S. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-105 · Cited by 21
“Recent studies found that the pRb/E2F cell-cycle pathway is activated in dopaminergic neurons in PD patients, as well as in a PD mouse model [34].”
Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models
Wang, H., Chen, Y., Chen, J., Zhang, Z., Lao, W., Li, X., Huang, J., & Wang, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109697 · Cited by 19
“Cyclin D was found to be upregulated in primary cultures of embryonic rat midbrain neurons after exposure to 1methyl-4-phenylpyridinium (MPP) [1].”
BackgroundInfluentialChen, M. J., Ng, J. M. J., Peng, Z. F., Manikandan, J., Yap, Y. W., Llanos, R. M., Beart, P. M., & Cheung, N. S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.015 · Cited by 18
“Cell cycle re-activation association to excitotoxicity has previously been reported on numerous occasions in models of excitotoxicity and stroke, amidst models of other neurodegenerative diseases such as the MPTP model of PD and superoxide dismutase-1 mouse model of ALS (Hoglinger et al., 2007; Nguyen et al., 2003; Ve…”
Rani, N., Sahu, M., Ambasta, R. K., & Kumar, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102174 · Cited by 18
Advani, D., & Kumar, P. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04130-7 · Cited by 16
“The alterations in Rb phosphorylation are associated with reduced transcriptional activity of E2F family members, the key players in the cell cycle arrest and apoptosis [139].”
Wang, Y., Shyam, N., Ting, J. H., Akay, C., Lindl, K. A., & Jordan‐Sciutto, K. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.032 · Cited by 17
de la Encarnación, A., Alquézar, C., & Martín‐Requero, Á. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9596-1 · Cited by 19
Sharma, R. K., Candelario‐Jalil, E., Feineis, D., Bringmann, G., Fiebich, B. L., & Akundi, R. S. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9782-1 · Cited by 16
“Forced re-entry into cell cycle causes apoptosis in these cells which has been observed in various PD models such as in cells treated with MPP+ (Camins et al. 2010) or 6-hydroxydopamine (Nair et al. 2006), and in post-mortem brain samples of PD patients (Hoglinger et al. 2007).”
BackgroundG93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis
Cova, E., Ghiroldi, A., Guareschi, S., Mazzini, G., Gagliardi, S., Davin, A., Bianchi, M., Ceroni, M., & Cereda, C. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.016 · Cited by 22
Goodnight, A., Kremsky, I., Khampang, S., Jung, Y. H., Billingsley, J. M., Bosinger, S. E., Corces, V. G., & Chan, A. W. S. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0313-6 · Cited by 18
Cell cycle deregulation in neurodegenerative diseases
Zhang, X., Song, S., & Peng, W. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1924705 · Cited by 15
“Third, they injected MPTP to E2F1-deficiency mice and found there were less nigral TH + cell loss than that in wild mice.”
BackgroundInfluentialATM and the epigenetics of the neuronal genome
Herrup, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.05.005 · Cited by 17
Cell-cycle Alterations in Post-mitotic Cells and Cell Death by Mitotic Catastrophe
Lombardi, D., & Lasagni, L. (2016) · InTech eBooks · doi:10.5772/61783 · Cited by 17
“reported in postmortem samples of PD patients.[99,100] Administration of 6-hydroxydopa‐”
Gardiner, K. L., Downs, L. M., Berta, A., Santana, E., Aguirre, G. D., & Genini, S. (2016) · BMC Genomics · doi:10.1186/s12864-016-2477-9 · Cited by 18
Jia, X., Chen, Q., Yao, C., Asakawa, T., & Zhang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116444 · Cited by 16
Role of l-thyroxin in counteracting rotenone induced neurotoxicity in rats
Salama, M., Helmy, B., El‐Gamal, M., Reda, A., Ellaithy, A., El‐Tantawy, D., Mohamed, M., Elgamal, A., Sheashaa, H., & Sobh, M. A. K. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.12.008 · Cited by 15
Yang, X., Chen, H., Zhu, M., Zhu, R., Qin, B., Fang, H., Dai, M., Sang, A., & Liu, X. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0211-9 · Cited by 13
Zyskind, J. W., Wáng, Y., Cho, G., Ting, J. H., Kolson, D. L., Lynch, D. R., & Jordan‐Sciutto, K. L. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12956 · Cited by 15
Vauzour, D., Pinto, J. T., Cooper, A. J. L., & Spencer, J. P. E. (2014) · Biochemical Journal · doi:10.1042/bj20131519 · Cited by 16
PARK16 is associated with PD in the Malaysian population
Gopalai, A. A., Ahmad‐Annuar, A., Li, H., Zhao, Y., Lim, S., Tan, A. H., Lim, T. T., Eow, G. B., Puvanarajah, S. D., Viswanathan, S., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32454 · Cited by 13
“The SNPs in PARK16 are in linkage disequilibrium (LD) with five genes (SLC45A3, NUCKS1, RAB7L1, SLC41A1, and FLJ32569), which could be linked to PD pathogenesis [H€oglinger et al., 2007; Kolisek et al., 2008; IPDGC, 2011].”
BackgroundAssociation between PARK16 and Parkinson’s disease: A meta-analysis
He, T., Wang, J., Wang, X., Deng, W., Jiang, H., Xie, J., & Sun, P. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.08.022 · Cited by 13
Marine bacterial extracts as a new rich source of drugs against Alzheimer’s disease
Zhu, B., Li, Z., Qian, P., & Herrup, K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14847 · Cited by 13
Biotech Park, S.-G. J., & Singh, S. (2019) · Bioinformation · doi:10.6026/97320630015548 · Cited by 14
Findeis, E., Schwarz, S. C., Evsyukov, V., Rösler, T. W., Höllerhage, M., Chakroun, T., Nykänen, N.-P., Shen, Y., Wurst, W., Kohl, M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.561086 · Cited by 15
Self-citationAlquézar, C., Esteras, N., Alzualde, A., Moreno, F., Ayuso, M. S., de Munaín, A. L., & Martín‐Requero, Á. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037057 · Cited by 15
“systemic manifestations of cell cycle-related events associated with neurodegeneration, as described in several diseases of the Central Nervous System (CNS) [46–49].”
Manganese induces p21 expression in PC12 cells at the transcriptional level
Zhao, F., Zhang, J.-B., Cai, T., Liu, X., Liu, M.-C., Ke, T., Chen, J.-Y., & Luo, W. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.027 · Cited by 13
Zhang, Z., Zhang, Z., Wang, H., Zhang, G., Hu, D., Xiong, J., Xiong, N., Wang, T., Cao, X., & Mao, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106669 · Cited by 15
“proliferating cells through the cell cycle to mitotic division [1,2,3].”
BackgroundTranscriptional dysregulation: a cause of dystonia?
Tamiya, G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70087-0 · Cited by 12
A Diagnostic Model for Parkinson’s Disease Based on Anoikis-Related Genes
Bao, Y., Wang, L., Liu, H., Yang, J., Yu, F., Cui, C., & Huang, D. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03753-6 · Cited by 11
“…Höglinger et al. found PCNA expression in the nigrostriatal dopaminergic neurons of PD patients as well as MPTP-treated mice but not in healthy neurons of normal controls, indicating that the death of dopaminergic neurons in PD is linked to abnormal activation of cell cycle-related signals [58].”
Urbaczek, A. C., Ribeiro, L. C. D. A., Ximenes, V. F., Afonso, A., Nogueira, C. T., Generoso, W. C., Alberice, J. V., Rudnicki, M., Ferrer, R., da Fonseca, L. M., et al. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276140090 · Cited by 11
“Additionally, VEGF-A plays a role in the regulation of several cellular functions, including growth (Nasimuzzaman et al. 2007) and apoptosis (Höglinger et al. 2007).”
BackgroundZhang, J., Bahí, N., Zubiaga, A. M., Comella, J. X., Llovera, M., & Sanchís, D. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.046 · Cited by 15
“[28,29,34]) could depend on the re-expression of the apoptotic signalling cascade in certain pathological conditions.”
BackgroundThe Contribution of Cdc2 in Rotenone-Induced G2/M Arrest and Caspase-3-Dependent Apoptosis
Wang, H., Zhang, Z., Huang, J., Zhang, P., Xiong, N., & Wang, T. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0185-3 · Cited by 11
“The events of mitosis were reactivated in the G2-state in dopaminergic cells in patients of PD (Höglinger et al. 2007).”
Dnmt1-dependent Chk1 pathway suppression is protective against neuron division
Oshikawa, M., Okada, K., Tabata, H., Nagata, K., & Ajioka, I. (2017) · Development · doi:10.1242/dev.154013 · Cited by 13
“For example, in Alzheimer’s disease (AD), Parkinson’s disease (PD) and a mouse model for stroke, neurons enter the S phase and then undergo cell death (El-Khodor et al., 2003; Hoglinger et al., 2007; Kuan et al., 2004; Yang et al., 2001).”
BackgroundMarchesi, L. T., Stockholm, D., Esteves, T., Leblanc, M., Auger, N., Branchu, J., Hachimi, K. H. E., & Stévanin, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-86337-9 · Cited by 10
“Aberrant expressions of E2F-1 or MYC transcription factor have been observed in neuron of patients with Parkinson’s disease 74 , Alzheimer’s disease 75,76 and ALS 77 .”
Current Conceptual View of Alzheimer’s Disease
Herrup, K. (2012) · Advances in biological psychiatry · doi:10.1159/000335378 · Cited by 12
Downregulation of BM88 After Optic Nerve Injury
Siddiqui, A. M., Sabljic, T. F., Koeberle, P. D., & Ball, A. K. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12986 · Cited by 11
Salama, M., El-Dakroory, S., El‐Tantawy, D., Ghanem, A. A., Abdel-ghaffar, H. A., Elhusseiny, M., & El-Hak, S. G. (2012) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.05.005 · Cited by 10
Proteomic profiling of early degenerative retina of RCS rats
Zhu, Z.-H., Fu, Y., Weng, C., Zhao, C., & Yin, Z. (2017) · International Journal of Ophthalmology · doi:10.18240/ijo.2017.06.08 · Cited by 10
Meng, L., He, M., Xiong, M., Zhang, X., Nie, S., Xiong, J., Hu, D., Zhang, Z., Mao, L., & Zhang, Z. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180798 · Cited by 9
Asai, H., Hirano, M., Kiriyama, T., Ikeda, M., & Ueno, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.141 · Cited by 10
“Consistent with this notion, cell cycle proteins are detectable in the SN of patients with Parkinson’s disease (PD) [8,9].”
BackgroundAdult Neurogenesis in Parkinson’s Disease
Mochizuki, H. (2011) · Springer eBooks · doi:10.1007/978-4-431-53945-2_2 · Cited by 11
“On the other hand, it was reported recently that mature neurons become immunopositive for proliferative cell markers in some neurodegenerative conditions (Hoglinger et al. 2007).”
BackgroundParkinson’s disease-associated alterations in DNA methylation and hydroxymethylation in human brain
Choza, J., Virani, M., Kuhn, N. C., Adams, M., Kochmanski, J. J., & Bernstein, A. I. (2025) · npj Parkinson's Disease · doi:10.1038/s41531-025-01209-3 · Cited by 15
Hargarten, J. C., Ssebambulidde, K., Anjum, S. H., Vaughan, M. J., Xu, J., Ganguly, A., Dulek, B., Otaizo-Carrasquero, F. A., Song, B., Tao, S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adi9885 · Cited by 12
Molecular Connections between DNA Replication and Cell Death in β-Amyloid-Treated Neurons
Caraci, F., Fidilio, A., Santangelo, R., Caruso, G., Giuffrida, M. L., Tomasello, M. F., Nicoletti, F., & Copani, A. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230404121903 · Cited by 8
“The reentry into the cell cycle of post-mitotic neurons has been associated with neuronal apoptosis also in Parkinson’s disease [2], Huntington’s disease [3], and amyotrophic lateral sclerosis (ALS) [4], leading to the hypothesis that reentering the cell cycle makes neurons prone to death.”
Prion-induced neurotoxicity: Possible role for cell cycle activity and DNA damage response
Bujdoso, R., Landgraf, M., Jackson, W. S., & Thackray, A. M. (2015) · World Journal of Virology · doi:10.5501/wjv.v4.i3.188 · Cited by 7
Biomaterial-engineering and neurobiological approaches for regenerating the injured cerebral cortex
Ajioka, I. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2016.02.002 · Cited by 8
An in vitro Model of Human Retinal Detachment Reveals Successive Death Pathway Activations
Potić, J., Mbefo, M. K., Berger, A., Nicolas, M., Wanner, D., Kostic, C., Matet, A., Béhar‐Cohen, F., Moulin, A., & Arsenijévic, Y. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.571293 · Cited by 8
Babu, A., & Urulangodi, M. (2023) · Genome Instability & Disease · doi:10.1007/s42764-023-00110-8 · Cited by 7
“Furthermore, investigations using postmortem brain samples from PD patients and experimental models have revealed abnormal expression of mitosis-associated proteins, such as the E2F-1 transcription factor, and dysregulation of cell cycle regulators in neurons (Höglinger et al., 2007).”
BackgroundPatterns of linkage disequilibrium at PARK16 may explain variances in genetic association studies
Li, H., Teo, Y., & Tan, E. (2015) · Movement Disorders · doi:10.1002/mds.26176 · Cited by 7
Zhang, Y., Zhu, B., Ma, F., & Herrup, K. (2021) · eNeuro · doi:10.1523/eneuro.0388-20.2020 · Cited by 10
“, 1998; Herrup and Yang, 2007), Parkinson’s disease (Höglinger et al., 2007), ALS (Ranganathan et al.”
BackgroundUp-regulation of SKIP relates to retinal ganglion cells apoptosis after optic nerve crush in vivo
Wu, Y., Xu, F., Huang, H., Chen, L., Wen, M., Jiang, L., Lu, L., Li, L., Song, D., Zeng, S., et al. (2014) · Journal of Molecular Histology · doi:10.1007/s10735-014-9589-9 · Cited by 7
Metadata
- Authors
- Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., & Hunot, S.
- Affiliations
- Inserm (FR)
- Yale University (US)
- Philipps University of Marburg (DE)
- *Department of Experimental Neurology, Philipps University, 35039 Marburg, Germany;
- University of Colorado Denver (US)
- Department of Experimental Neurology and Therapeutics, Unité Mixte de Recherche 679, Institut National de la Santé et de la Recherche Médicale, 75013 Paris, France;
- Corresponding author
- Rakic, Pasko
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-02-27
- Volume
- 104
- Issue
- 9
- Pages
- 3585-3590
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1805567
- OpenAlex
- W2092598865
- Cited by
- 276
- References
- 25
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 14 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 22 · 2014: 17 · 2013: 19 · 2012: 16
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (LSHM-CT-2003-503330)
- Bundesministerium für Bildung und Forschung (01GO0201, BMBF-01GN0513, 01GN0513)
- National Institute of Mental Health (R24MH068855, R24MH68855)
- National Cancer Institute (R01CA077314)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, dopaminergic neurons, substantia nigra, retinoblastoma protein, E2F1, cell cycle, neuronal cell death, MPTP, MPP+, DNA replication, neuroprotection, postmitotic neurons
- MeSH terms
- Analysis of Variance, Animals, Chromatography, High Pressure Liquid, Gene Expression Regulation, Humans, Immunohistochemistry, Interneurons, Male, Mice, Inbred C57BL, Parkinson Disease, Substantia Nigra, Signal Transduction, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-Methyl-4-phenylpyridinium, Oligonucleotides, Antisense, Apoptosis, In Situ Hybridization, Mice, Knockout, E2F1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.